Medtronic logo

Medtronic

Medtronic makes implantable devices, surgical systems, and monitoring equipment for hospitals and specialists, with teams in more than 150 countries.

ShareLink copied

The record

Vertical
Devices & Robotics
Sub-segment
Cardiovascular, neuroscience and surgical devices
Product type
Device
Stage
Public
Headquarters
Galway, Ireland
Region
Europe
Founded
1949

What they do

Medtronic organizes its business into three portfolios: Cardiovascular, Neuroscience, and Surgical. Its products include cardiac devices, surgical robotics, surgical tools, and patient monitoring systems, and the company says its therapies treat 70 health conditions. Most of its customers are hospitals, health systems, and the specialists who implant or operate its devices. In October 2026 Medtronic completed the separation of its diabetes business, MiniMed Group, which now trades on Nasdaq as a separate company. Medtronic is listed on the New York Stock Exchange. Its legal headquarters is in Galway, and its operational headquarters is in Minneapolis. On 16 November 2026, Medtronic announced its intent to acquire Contego Medical for $380 million plus potential post-acquisition payments. Closing is expected in its fiscal third quarter, subject to customary conditions. The transaction includes Neuroguard IEP Direct and Excipio devices. Medtronic expects minimal adjusted EPS dilution in FY27 and FY28.

Leadership & founders

Leadership as of 14 November 2026.

History and progression

How Medtronic got here, step by step.

  1. 16 November 2026

    Planned Contego Medical acquisition

    On 16 November 2026, Medtronic announced its intent to acquire Contego Medical for $380 million plus potential post-acquisition payments. Closing is expected in its fiscal third quarter, subject to customary conditions. The transaction includes Neuroguard IEP Direct and Excipio devices. Medtronic expects minimal adjusted EPS dilution in FY27 and FY28.

Recent news

  1. 16 November 2026

    Planned Contego Medical acquisition
  2. 16 November 2026

    David Moeller, SVP and President, Peripheral Vascular Health
  3. 16 November 2026

    Linnea Burman, SVP and President, Neurovascular

In The HealthTech Signal

Related companies

Is this your company? Get a Verified profile